These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3896873)

  • 1. Instability of resistance of Plasmodium falciparum to chloroquine and pyrimethamine in vitro.
    Sinha S; Gajanana A; Sivaraman CA
    Indian J Malariol; 1985 Jun; 22(1):49-51. PubMed ID: 3896873
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic evidence for Plasmodium falciparum resistance to chloroquine and pyrimethamine in Indochina and the Western Pacific between 1984 and 1998.
    Saito-Nakano Y; Tanabe K; Kamei K; Iwagami M; Komaki-Yasuda K; Kawazu S; Kano S; Ohmae H; Endo T
    Am J Trop Med Hyg; 2008 Oct; 79(4):613-9. PubMed ID: 18840753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
    Djaman AJ; Basco LK; Mazabraud A
    Sante; 2002; 12(4):363-7. PubMed ID: 12626289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroquine and sulfadoxine/pyrimethamine sensitivity in Burkina Faso. In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Burkina Faso.
    Del Nero L; Nebie I; Soudouem G; Pietra V
    Trop Geogr Med; 1994; 46(1):8-10. PubMed ID: 8165742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
    Djaman J; Abouanou S; Basco L; Koné M
    Sante; 2004; 14(4):205-9. PubMed ID: 15745869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to chloroquine with and without pyrimethamine in Plasmodium falciparum in West Bengal, Tripura, Mizoram, Manipur and Arunachal Pradesh.
    Pattanayak S; Roy RG; Sen N
    Indian J Med Res; 1979 Dec; 70 Suppl():48-51. PubMed ID: 398338
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanisms and dynamics of drug resistance in Plasmodium falciparum].
    Le Bras J
    Bull Soc Pathol Exot; 1999; 92(4):236-41. PubMed ID: 10572658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium falciparum: drug-resistant malaria complicating leukemias and lymphomas in children.
    Nirmala ; Kumar A; Kapoor AK; Lal B; Dutta GP; Swaroop A
    Exp Parasitol; 1999 Sep; 93(1):33-7. PubMed ID: 10464036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in western Uganda.
    Kamugisha J; Kipp W; Burnham G
    Trop Geogr Med; 1994; 46(6):364-5. PubMed ID: 7892705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulphadoxine-pyrimethamine and chloroquine resistant Plasmodium falciparum infection in Sri Lanka.
    Handunnetti SM; Jayasinghe S; Pathirana PP; Fernando R; Sheriff MH; Mendis KN
    Ceylon Med J; 1994 Mar; 39(1):45-6. PubMed ID: 8194148
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of sulfadoxine-pyrimethamine in chloroquine resistant falciparum malaria in Bombay.
    Garg MR; Gogtay NJ; Kshirsagar NA
    J Assoc Physicians India; 1996 Oct; 44(10):683-5. PubMed ID: 9251339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism of cimetidine with anti-malarial agents.
    Paciorkowski A; Dai WW; Cerami A; Berger BJ
    J Parasitol; 1997 Oct; 83(5):960-3. PubMed ID: 9379310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the response in vivo and in vitro of Plasmodium falciparum to sulphadoxine-pyrimethamine in the malarious areas of Iran.
    Edrissian GH; Afshar A; Sayedzadeh A; Mohsseni G; Satvat MT
    J Trop Med Hyg; 1993 Aug; 96(4):237-40. PubMed ID: 8345544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso.
    Del Nero L; Lamizana L; Pietra V; Nebié I
    Parassitologia; 1994 Dec; 36(3):287-93. PubMed ID: 7637999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro sensitivity of Plasmodium falciparum to amodiaquine compared with other major antimalarials in Madagascar.
    Randrianarivelojosia M; Harisoa JL; Rabarijaona LP; Raharimalala LA; Ranaivo L; Pietra V; Duchemin JB; Rakotomanana F; Robert V; Mauclere P; Ariey F
    Parassitologia; 2002 Dec; 44(3-4):141-7. PubMed ID: 12701375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.
    Osman ME; Mockenhaupt FP; Bienzle U; Elbashir MI; Giha HA
    Infect Genet Evol; 2007 Jan; 7(1):52-9. PubMed ID: 16690361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished Plasmodium falciparum sensitivity to quinine exposure in vitro and in a sequential multi-drug regimen: A preliminary investigation in Guyana, South America.
    Best Plummer W; Pinto Pereira L
    Int J Infect Dis; 2008 Nov; 12(6):e27-31. PubMed ID: 18573671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro study assessing the response of plasmodium falciparum malaria to chloroquine, sulfadoxine/pyrimethamine, quinine and mefloquine in Wad Medani District, Sudan.
    Nour BY; Faragalla IA; Saeed OK; Mohamadani AA
    Saudi Med J; 2006 Jun; 27(6):808-12. PubMed ID: 16758040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine resistance in P. falciparum in Assam State.
    Pattanayak S; Roy RG; Phukan D; Barkakuty BN
    Indian J Med Res; 1979 Dec; 70 Suppl():14-9. PubMed ID: 398331
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of a 3-day oral regimen of quinine in an area of northern Nigeria with low-grade resistance of Plasmodium falciparum to chloroquine and sulphadoxine-pyrimethamine.
    Adagu SI; Okoyeh JN; Lege-Oguntoye L; Ogala WN; Ogunrinde GO; Faji JT; Sani AH
    J Trop Med Hyg; 1995 Oct; 98(5):296-8. PubMed ID: 7563254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.